Analyst stock forecast
Altimmune Forecast: $17.11 Analyst Target
Direct answer
Altimmune's average price target is $17.11.
The target implies +476.1% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +270.4%, the high target implies +842.8%, and the range spans 572.4% of the current price.
Forecast evidence checked September 30, 2026.
Get free Altimmune email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.97
- Average price target
- $17.11
- High price target
- $28.00
- Low price target
- $11.00
- Low target gap
- +270.4%
- Target upside
- +476.1%
- High target gap
- +842.8%
- Target range width
- 572.4%
- Consensus rating
- Strong Buy
- Analysts
- 9
- Evidence date
- September 30, 2026
- Valid through
- October 7, 2026
Explore related company data
Read the frequently asked questions.
What is Altimmune's average price target?
Altimmune's verified average price target is $17.11. The target range is $11.00 to $28.00.
How far are Altimmune's low and high targets from the recorded price?
The low target implies +270.4%, while the high target implies +842.8%.
How many analysts are included in Altimmune's consensus?
The verified consensus includes 9 analysts.
How is Altimmune's target upside or downside calculated?
The average target of $17.11 is divided by the recorded price of $2.97, then one is subtracted to produce +476.1%. This does not guarantee a future return.
When was Altimmune's analyst forecast verified?
The data was verified on 2026-09-30. The dataset is valid through 2026-10-07.